Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mohammad Khandwala"'
Autor:
Derek S. Tsang, Grace Tsui, Chris McIntosh, Thomas Purdie, Glenn Bauman, Hitesh Dama, Normand Laperriere, Barbara-Ann Millar, David B. Shultz, Sameera Ahmed, Mohammad Khandwala, David C. Hodgson
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-6 (2022)
Abstract Purpose High-quality radiotherapy (RT) planning for children and young adults with primary brain tumours is essential to minimize the risk of late treatment effects. The feasibility of using automated machine-learning (ML) to aid RT planning
Externí odkaz:
https://doaj.org/article/9afe593b499341e6a5e672a6c3515d4b
Autor:
Mohammad Khandwala, Sameera Ahmed, Vicky Papaioannou, Derek S. Tsang, Annie Huang, David C. Hodgson, Donald J. Mabbott, Eric Bouffet, Ryan Yee, Dana Keilty, Uri Tabori, Ute Bartels, Normand Laperriere, Sharon L. Cushing, Vijay Ramaswamy, Zhihui Amy Liu
Publikováno v:
Journal of Clinical Oncology. 39:3813-3821
PURPOSE Hearing loss (HL) is a serious secondary effect of treatment for CNS and head-and-neck tumors in children. The goal of this study was to evaluate incidence and risk factors for HL in patients with multiple ototoxic exposures. PATIENTS AND MET
Autor:
Donald J. Mabbott, Uri Tabori, Derek S. Tsang, Zhihui Amy Liu, Mohammad Khandwala, Dana Keilty, Sharon L. Cushing, Annie Huang, V Papioannou, Ryan Yee, Normand Laperriere, Ute Bartels, Eric Bouffet, David C. Hodgson, Vijay Ramaswamy, Sameera Ahmed
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e171-e172
Purpose/objective(s) Hearing loss (HL) is a serious secondary effect of treatment for head and neck (HN however, combined modality treatment is routinely used and the effect of chemoradiation on HL risk is not well-studied. Using chemotherapy and coc
Autor:
David C. Hodgson, Dana Keilty, Donald J. Mabbott, Hitesh Dama, Timothy J. Craig, Zhihui Amy Liu, Derek S. Tsang, Vijay Ramaswamy, Normand Laperriere, Mohammad Khandwala, Laurence Kim, Laura Janzen, Eric Bouffet
Publikováno v:
Neuro Oncol
Background The objective of this study was to evaluate the contribution of radiation dose to different intracranial structures on changes in intellectual function for children with brain tumors. Methods We evaluated children with brain tumors treated
Autor:
Normand Laperriere, Vicky Papaioannou, Donald J. Mabbott, Dana Keilty, Ute Bartels, Sharon L. Cushing, Sameera Ahmed, Derek S. Tsang, Annie Huang, Zhihui Amy Liu, Uri Tabori, Mohammad Khandwala, Ryan Yee, Vijay Ramaswamy, David R. W. Hodgson, Eric Bouffet
Publikováno v:
Radiotherapy and Oncology. 163:S20
Autor:
David C. Hodgson, Chris McIntosh, Mohammad Khandwala, Thomas G. Purdie, Glenn Bauman, Derek S. Tsang, Grace Tsui, Hitesh Dama, Normand Laperriere
Publikováno v:
Journal of Medical Imaging and Radiation Sciences. 52:S3
Autor:
Derek S. Tsang, Normand Laperriere, Zhihui Amy Liu, Laurence Kim, Lauran Janzen, David C. Hodgson, Dana Keilty, Donald Mabbott, Eric Bouffet, Mohammad Khandwala, Hitesh Dama, Vijay Ramaswamy
Publikováno v:
Neuro-Oncology
INTRODUCTION The contribution of different intracranial structures on neurocognitive decline after radiation therapy (RT) in children is unclear. METHODS This was a retrospective study of children with brain tumours treated from 2005 to 2017. Patient
Autor:
Mohammad Khandwala, Dana Keilty, Donald J. Mabbott, N.J. Laperriere, L. Kim, Derek S. Tsang, Vijay Ramaswamy, Hitesh Dama, L. Janzen, David R. W. Hodgson, Z. Liu, Eric Bouffet
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:S126
Autor:
Chris McIntosh, Grace Tsui, Derek S. Tsang, Mohammad Khandwala, Hitesh Dama, Glenn Bauman, Normand Laperriere, Thomas G. Purdie, David R. W. Hodgson
Publikováno v:
Radiotherapy and Oncology. 150:S15
Autor:
Emily Quinn, Aaron H. Phillips, Emilia M. Pinto, Santhosh A. Upadhyaya, Gerard P. Zambetti, Chimene Kesserwan, Kim E. Nichols, Mohammad Khandwala, David W. Ellison, Richard W. Kriwacki, Jamie L. Maciaszek, David Berdy
Publikováno v:
Cold Spring Harbor Molecular Case Studies
Li–Fraumeni syndrome (LFS) is a highly penetrant cancer predisposition syndrome caused by heterozygous germline mutations in the TP53 gene. Although more than 200 missense and null TP53 mutations are well established as disease-causing, little is k